NCYT:LON
Novacyt SA
39,50 GBX
arrow_downward
-0,25%(-0,100) 1D
16 tet, 4:35:25 m.d., GMT+1 · GBX
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për NCYT...
Hap
39,60 GBX
I lartë
39,68 GBX
I ulët
39,20 GBX
Kapitalizimi i tregut
32,41 mln
Vëllimi mesatar
102,63 mijë
Vëllimi
12,22 mijë
Maksimumi 52-javor
86,00 GBX
Minimumi 52-javor
26,60 GBX
Aksionet në qarkullim
37,66 mln
Numri i punonjësve
228
Hap
39,60 GBX
I lartë
39,68 GBX
I ulët
39,20 GBX
Kapitalizimi i tregut
32,41 mln
Vëllimi mesatar
102,63 mijë
Vëllimi
12,22 mijë
Maksimumi 52-javor
86,00 GBX
Minimumi 52-javor
26,60 GBX
Aksionet në qarkullim
37,66 mln
Numri i punonjësve
228
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Yahoo Finance
·
23 minuta më parë
Missing the S&P 500's 10 Best Days in 20 Years Cut a $10,000 Investment's Ending Value by More Than Half
Binance
·
12 minuta më parë
Binance Market Update | S&P 500 Near a Record While Half the Russell 3000 Is in a Bear Market — Bitcoin Held as AI Credit Spreads Blew Out and Strategy Fell 9%
ChartMill
·
55 minuta më parë
HONGLI GROUP INC (NASDAQ:HLP) Passes Minervini Trend Template and High-Growth Momentum Screen
MarketWatch
·
13 orë më parë
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profili
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Rreth Novacyt SA
Drejtori ekzekutivDavid Allmond
Punonjësit228
Themeluar më3 korr 2006
Selia-
Sektori-
Uebsajtinovacyt.com